Atefy Ramin, Tettenborn Barbara
Department of Neurology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland.
Epilepsy Behav. 2005 Jun;6(4):613-6. doi: 10.1016/j.yebeh.2005.03.015.
In several studies the efficacy and tolerability of levetiracetam (LEV) have been demonstrated. We report two patients who developed nonconvulsive status epilepticus on treatment with LEV. Both patients never experienced status epilepticus before. One patient had a symptomatic epilepsy with complex partial seizures following radiotherapy of astrocytoma in 1985; the second patient had complex partial seizures due to mesial temporal sclerosis. Both patients received LEV 2000 mg/day. We postulate a correlation between occurrence of nonconvulsive status and treatment with LEV. This has not been described before apart from a single report of mentally retarded patients with status epilepticus on high dosages of LEV.
在多项研究中已证实左乙拉西坦(LEV)的疗效和耐受性。我们报告了两名在使用LEV治疗期间发生非惊厥性癫痫持续状态的患者。两名患者此前从未经历过癫痫持续状态。一名患者在1985年星形细胞瘤放疗后出现有症状性癫痫伴复杂部分性发作;第二名患者因内侧颞叶硬化症出现复杂部分性发作。两名患者均接受每日2000毫克的LEV治疗。我们推测非惊厥性癫痫持续状态的发生与LEV治疗之间存在关联。除了一份关于高剂量LEV治疗的智障癫痫持续状态患者的单一报告外,此前尚未有过此类描述。